References
- Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest 1981;68:611–20.
- Rigolet A, Musset L, Dubourg O, Maisonobe T, Grenier P, Charuel JL, et al. Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine (Baltimore) 2012;91:95–102.
- Yoshida T, Yoshida M, Mitsuyo K, Jonosono M, Higuchi I. Dropped head syndrome and the presence of rimmed vacuoles in a muscle biopsy in scleroderma-polymyositis overlap syndrome associated with anti-ku antibody. Intern Med 2018;57:887–91.
- Awano N, Fukuda K, Sakayori M, Kondoh K, Ono R, Moriya A, et al. Sarcoid myositis with anti-ku antibody consistent with both sarcoidosis and polymyositis. Intern Med 2016;55:2049–53.
- Ogawa-Momohara M, Muro Y, Akiyama M. Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients. Ann Rheum Dis. Published online 2019 October 11;annrheumdis-2019-216375. doi:https://doi.org/10.1136/annrheumdis-2019-216375
- Askanas V, Engel WK. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains. Acta Neuropathol 2008;116:583–95.
- Amato AA, Barohn RJ. Inclusion body myositis: old and new c7oncepts. J Neurol Neurosurg Psychiatry 2009;80:1186–93.
- Salajegheh M, Lam T, Greenberg SA. Autoantibodies against a 43 KDa muscle protein in inclusion body myositis. PLoS One 2011;6:e20266.
- Kadowaki Y, Horino T, Kashio T, Nishikawa H, Inotani S, Matsumoto T, et al. Anti-Ku antibody-related scleroderma-polymyositis overlap syndrome associated with hypothyroid myopathy. J Clin Rheumatol. Published online: 25 April 2020. doi:https://doi.org/10.1097/RHU.0000000000001395.
- Kamei N, Yamane K, Yamashita Y, Nakanishi S, Watanabe H, Fujikawa R, et al. Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves’ disease and immune thrombocytopenic purpura. Intern Med 2002;41:1199–203.